Global Active Pharmaceutical Ingredients Market

Global Active Pharmaceutical Ingredients (API) Market Research Report 2021

Global Active Pharmaceutical Ingredients Market

Global Active Pharmaceutical Ingredients (API) Market Research Report 2021

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

Research Predicts that Active Pharmaceutical Ingredients (API) Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.

Global Active Pharmaceutical Ingredients (API) Market Overview:

Global Active Pharmaceutical Ingredients (API) Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Active Pharmaceutical Ingredients (API) involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.

Impact of COVID-19 on Active Pharmaceutical Ingredients (API) Market

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Active Pharmaceutical Ingredients (API) market in 2020.

Global Active Pharmaceutical Ingredients (API) Market Segmentation

By Type, Active Pharmaceutical Ingredients (API) market has been segmented into:

Vitamin

Antibiotics

Antipyretic & Analgesic

Hormone

Amino Acid

Nervus Centralis

Others

By Application, Active Pharmaceutical Ingredients (API) market has been segmented into:

Hospital

Clinic

Others

Regional Analysis:

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

Top Key Players Covered in Active Pharmaceutical Ingredients (API) market are:

Teva Active Pharmaceutical Industries Limited

DSM

Novartis

Roche

Johnson & Johnson

Dr. Reddy s

Pfizer

Bayer

BASF

Cambrex

Sun Pharmaceutical Industries

Lonza group

Boehringer Ingelheim GmbH

Aurobindo pharma

1. Market Overview of Active Pharmaceutical Ingredients (API)

1.1 Active Pharmaceutical Ingredients (API) Market Overview

1.1.1 Active Pharmaceutical Ingredients (API) Product Scope

1.1.2 Market Status and Outlook

1.2 Active Pharmaceutical Ingredients (API) Market Size by Regions: 2015 VS 2021 VS 2026

1.3 Active Pharmaceutical Ingredients (API) Historic Market Size by Regions (2015-2020)

1.4 Active Pharmaceutical Ingredients (API) Forecasted Market Size by Regions (2021-2026)

1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)

1.5.1 North America

1.5.2 East Asia

1.5.3 Europe

1.5.4 South Asia

1.5.5 Southeast Asia

1.5.6 Middle East

1.5.7 Africa

1.5.8 Oceania

1.5.9 South America

1.5.10 Rest of the World

1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.6.2 Covid-19 Impact: Commodity Prices Indices

1.6.3 Covid-19 Impact: Global Major Government Policy

2. Covid-19 Impact Active Pharmaceutical Ingredients (API) Sales Market by Type (2015-2026)

2.1 Global Active Pharmaceutical Ingredients (API) Historic Market Size by Type (2015-2020)

2.2 Global Active Pharmaceutical Ingredients (API) Forecasted Market Size by Type (2021-2026)

2.3 Vitamin

2.4 Antibiotics

2.5 Antipyretic & Analgesic

2.6 Hormone

2.7 Amino Acid

2.8 Nervus Centralis

2.9 Others

3. Covid-19 Impact Active Pharmaceutical Ingredients (API) Sales Market by Application (2015-2026)

3.1 Global Active Pharmaceutical Ingredients (API) Historic Market Size by Application (2015-2020)

3.2 Global Active Pharmaceutical Ingredients (API) Forecasted Market Size by Application (2021-2026)

3.3 Hospital

3.4 Clinic

3.5 Others

4. Covid-19 Impact Market Competition by Manufacturers

4.1 Global Active Pharmaceutical Ingredients (API) Production Capacity Market Share by Manufacturers (2015-2020)

4.2 Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Manufacturers (2015-2020)

4.3 Global Active Pharmaceutical Ingredients (API) Average Price by Manufacturers (2015-2020)

5. Company Profiles and Key Figures in Active Pharmaceutical Ingredients (API) Business

5.1 Teva Active Pharmaceutical Industries Limited

5.1.1 Teva Active Pharmaceutical Industries Limited Company Profile

5.1.2 Teva Active Pharmaceutical Industries Limited Active Pharmaceutical Ingredients (API) Product Specification

5.1.3 Teva Active Pharmaceutical Industries Limited Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.2 DSM

5.2.1 DSM Company Profile

5.2.2 DSM Active Pharmaceutical Ingredients (API) Product Specification

5.2.3 DSM Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.3 Novartis

5.3.1 Novartis Company Profile

5.3.2 Novartis Active Pharmaceutical Ingredients (API) Product Specification

5.3.3 Novartis Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.4 Roche

5.4.1 Roche Company Profile

5.4.2 Roche Active Pharmaceutical Ingredients (API) Product Specification

5.4.3 Roche Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.5 Johnson & Johnson

5.5.1 Johnson & Johnson Company Profile

5.5.2 Johnson & Johnson Active Pharmaceutical Ingredients (API) Product Specification

5.5.3 Johnson & Johnson Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.6 Dr. Reddy s

5.6.1 Dr. Reddy s Company Profile

5.6.2 Dr. Reddy s Active Pharmaceutical Ingredients (API) Product Specification

5.6.3 Dr. Reddy s Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.7 Pfizer

5.7.1 Pfizer Company Profile

5.7.2 Pfizer Active Pharmaceutical Ingredients (API) Product Specification

5.7.3 Pfizer Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.8 Bayer

5.8.1 Bayer Company Profile

5.8.2 Bayer Active Pharmaceutical Ingredients (API) Product Specification

5.8.3 Bayer Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.9 BASF

5.9.1 BASF Company Profile

5.9.2 BASF Active Pharmaceutical Ingredients (API) Product Specification

5.9.3 BASF Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.10 Cambrex

5.10.1 Cambrex Company Profile

5.10.2 Cambrex Active Pharmaceutical Ingredients (API) Product Specification

5.10.3 Cambrex Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.11 Sun Pharmaceutical Industries

5.11.1 Sun Pharmaceutical Industries Company Profile

5.11.2 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Product Specification

5.11.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.12 Lonza group

5.12.1 Lonza group Company Profile

5.12.2 Lonza group Active Pharmaceutical Ingredients (API) Product Specification

5.12.3 Lonza group Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.13 Boehringer Ingelheim GmbH

5.13.1 Boehringer Ingelheim GmbH Company Profile

5.13.2 Boehringer Ingelheim GmbH Active Pharmaceutical Ingredients (API) Product Specification

5.13.3 Boehringer Ingelheim GmbH Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.14 Aurobindo pharma

5.14.1 Aurobindo pharma Company Profile

5.14.2 Aurobindo pharma Active Pharmaceutical Ingredients (API) Product Specification

5.14.3 Aurobindo pharma Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2015-2020)

6. North America

6.1 North America Active Pharmaceutical Ingredients (API) Market Size (2015-2026)

6.2 North America Active Pharmaceutical Ingredients (API) Key Players in North America (2015-2020)

6.3 North America Active Pharmaceutical Ingredients (API) Market Size by Type (2015-2020)

6.4 North America Active Pharmaceutical Ingredients (API) Market Size by Application (2015-2020)

7. East Asia

7.1 East Asia Active Pharmaceutical Ingredients (API) Market Size (2015-2026)

7.2 East Asia Active Pharmaceutical Ingredients (API) Key Players in North America (2015-2020)

7.3 East Asia Active Pharmaceutical Ingredients (API) Market Size by Type (2015-2020)

7.4 East Asia Active Pharmaceutical Ingredients (API) Market Size by Application (2015-2020)

8. Europe

8.1 Europe Active Pharmaceutical Ingredients (API) Market Size (2015-2026)

8.2 Europe Active Pharmaceutical Ingredients (API) Key Players in North America (2015-2020)

8.3 Europe Active Pharmaceutical Ingredients (API) Market Size by Type (2015-2020)

8.4 Europe Active Pharmaceutical Ingredients (API) Market Size by Application (2015-2020)

9. South Asia

9.1 South Asia Active Pharmaceutical Ingredients (API) Market Size (2015-2026)

9.2 South Asia Active Pharmaceutical Ingredients (API) Key Players in North America (2015-2020)

9.3 South Asia Active Pharmaceutical Ingredients (API) Market Size by Type (2015-2020)

9.4 South Asia Active Pharmaceutical Ingredients (API) Market Size by Application (2015-2020)

10. Southeast Asia

10.1 Southeast Asia Active Pharmaceutical Ingredients (API) Market Size (2015-2026)

10.2 Southeast Asia Active Pharmaceutical Ingredients (API) Key Players in North America (2015-2020)

10.3 Southeast Asia Active Pharmaceutical Ingredients (API) Market Size by Type (2015-2020)

10.4 Southeast Asia Active Pharmaceutical Ingredients (API) Market Size by Application (2015-2020)

11. Middle East

11.1 Middle East Active Pharmaceutical Ingredients (API) Market Size (2015-2026)

11.2 Middle East Active Pharmaceutical Ingredients (API) Key Players in North America (2015-2020)

11.3 Middle East Active Pharmaceutical Ingredients (API) Market Size by Type (2015-2020)

11.4 Middle East Active Pharmaceutical Ingredients (API) Market Size by Application (2015-2020)

12. Africa

12.1 Africa Active Pharmaceutical Ingredients (API) Market Size (2015-2026)

12.2 Africa Active Pharmaceutical Ingredients (API) Key Players in North America (2015-2020)

12.3 Africa Active Pharmaceutical Ingredients (API) Market Size by Type (2015-2020)

12.4 Africa Active Pharmaceutical Ingredients (API) Market Size by Application (2015-2020)

13. Oceania

13.1 Oceania Active Pharmaceutical Ingredients (API) Market Size (2015-2026)

13.2 Oceania Active Pharmaceutical Ingredients (API) Key Players in North America (2015-2020)

13.3 Oceania Active Pharmaceutical Ingredients (API) Market Size by Type (2015-2020)

13.4 Oceania Active Pharmaceutical Ingredients (API) Market Size by Application (2015-2020)

14. South America

14.1 South America Active Pharmaceutical Ingredients (API) Market Size (2015-2026)

14.2 South America Active Pharmaceutical Ingredients (API) Key Players in North America (2015-2020)

14.3 South America Active Pharmaceutical Ingredients (API) Market Size by Type (2015-2020)

14.4 South America Active Pharmaceutical Ingredients (API) Market Size by Application (2015-2020)

15. Rest of the World

15.1 Rest of the World Active Pharmaceutical Ingredients (API) Market Size (2015-2026)

15.2 Rest of the World Active Pharmaceutical Ingredients (API) Key Players in North America (2015-2020)

15.3 Rest of the World Active Pharmaceutical Ingredients (API) Market Size by Type (2015-2020)

15.4 Rest of the World Active Pharmaceutical Ingredients (API) Market Size by Application (2015-2020)

16 Active Pharmaceutical Ingredients (API) Market Dynamics

16.1 Covid-19 Impact Market Top Trends

16.2 Covid-19 Impact Market Drivers

16.3 Covid-19 Impact Market Challenges

16.4 Porter’s Five Forces Analysis

18 Regulatory Information

17 Analyst's Viewpoints/Conclusions

18 Appendix

18.1 Research Methodology

18.1.1 Methodology/Research Approach

18.1.2 Data Source

18.2 Disclaimer

Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Active Pharmaceutical Ingredients (API) Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Who are the dominant players having a strong presence in the Active Pharmaceutical Ingredients (API) Market?
Some of the finest and top-notch companies pioneering the Active Pharmaceutical Ingredients (API) Market are Teva Active Pharmaceutical Industries Limited, DSM, Novartis, Roche, Johnson & Johnson, Dr. Reddy s, Pfizer, Bayer, BASF, Cambrex, Sun Pharmaceutical Industries, Lonza group, Boehringer Ingelheim GmbH, Aurobindo pharma.
What trends are influencing the growth of the Active Pharmaceutical Ingredients (API) Market?
New players are entering the Active Pharmaceutical Ingredients (API) Market, while established companies are changing their business models and strategies. This pattern is likely to continue for the foreseeable future.
Where are the Active Pharmaceutical Ingredients (API) used?
The Active Pharmaceutical Ingredients (API) are employed in Hospital, Clinic, Others.
What is the current state of the Active Pharmaceutical Ingredients (API) Industry, and what is the projected growth trajectory through 2030?
In 2024, the Active Pharmaceutical Ingredients (API) Market share surpassed USD xx million, and between 2025 and 2030, it will grow at a CAGR of yy%.
What are the underlying opportunities in the Active Pharmaceutical Ingredients (API) Market?
The influx of capital into the Active Pharmaceutical Ingredients (API) Market, as well as the deployment of technologies designed to increase efficiency and yield high volume, are paving the way for promising market opportunities.
What is the estimated global market value of the Active Pharmaceutical Ingredients (API) Market?
The Active Pharmaceutical Ingredients (API) Market is expected to reach a considerable market valuation.